sq-11725 has been researched along with Death, Sudden, Cardiac in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abu-Zeitone, A; McNitt, S; Moss, AJ; Peterson, DR; Polonsky, B | 1 |
| Schwartz, PJ | 1 |
| Coumel, P; Denjoy, I; Grau, F; Leenhardt, A; Lucet, V; Ngoc, DD | 1 |
| Alessi, SR; de Paola, AA; Leite, LR; Ponzi Pereira, KR | 1 |
4 other study(ies) available for sq-11725 and Death, Sudden, Cardiac
| Article | Year |
|---|---|
Efficacy of different beta-blockers in the treatment of long QT syndrome.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Atenolol; Child; Child, Preschool; Death, Sudden, Cardiac; Female; Genotype; Heart Arrest; Humans; Infant; Infant, Newborn; Long QT Syndrome; Male; Metoprolol; Multivariate Analysis; Nadolol; Proportional Hazards Models; Propranolol; Registries; Regression Analysis; Risk Factors; Syncope; Time Factors; Treatment Outcome; Young Adult | 2014 |
Pharmacological and non-pharmacological management of the congenital long QT syndrome: the rationale.
Topics: Adrenergic beta-Antagonists; Death, Sudden, Cardiac; Defibrillators, Implantable; Humans; Long QT Syndrome; Nadolol; Propranolol | 2011 |
Catecholaminergic polymorphic ventricular tachycardia in children. A 7-year follow-up of 21 patients.
Topics: Adrenergic beta-Antagonists; Child; Death, Sudden, Cardiac; Electrocardiography; Exercise Test; Female; Follow-Up Studies; Humans; Long QT Syndrome; Male; Nadolol; Risk Factors; Syncope; Tachycardia, Ventricular; Time Factors | 1995 |
Catecholaminergic polymorphic ventricular tachycardia. An important diagnosis in children with syncope and normal heart.
Topics: Adrenergic beta-Antagonists; Child; Death, Sudden, Cardiac; Electrocardiography; Female; Follow-Up Studies; Humans; Nadolol; Syncope; Tachycardia, Ventricular | 2001 |